132 related articles for article (PubMed ID: 37209099)
1. Genome-wide identification of aberrant alternative splicing and RNA-binding protein regulators in acute myeloid leukaemia which may contribute to immune microenvironment remodelling.
Yang Y; Zhang YM; Wang Y; Liu K; Cui SY; Luo YQ; Zheng W; Xu J; Duan W; Wang JY
Carcinogenesis; 2023 Aug; 44(5):418-425. PubMed ID: 37209099
[TBL] [Abstract][Full Text] [Related]
2. Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia.
Wang E; Lu SX; Pastore A; Chen X; Imig J; Chun-Wei Lee S; Hockemeyer K; Ghebrechristos YE; Yoshimi A; Inoue D; Ki M; Cho H; Bitner L; Kloetgen A; Lin KT; Uehara T; Owa T; Tibes R; Krainer AR; Abdel-Wahab O; Aifantis I
Cancer Cell; 2019 Mar; 35(3):369-384.e7. PubMed ID: 30799057
[TBL] [Abstract][Full Text] [Related]
3. Splicing factor-mediated regulation patterns reveals biological characteristics and aid in predicting prognosis in acute myeloid leukemia.
Zhong FM; Yao FY; Liu J; Li MY; Jiang JY; Cheng Y; Xu S; Li SQ; Zhang N; Huang B; Wang XZ
J Transl Med; 2023 Jan; 21(1):6. PubMed ID: 36611187
[TBL] [Abstract][Full Text] [Related]
4. Distinct noncoding RNAs and RNA binding proteins associated with high-risk pediatric and adult acute myeloid leukemias detected by regulatory network analysis.
Liu Z; Spiegelman VS; Wang HG
Cancer Rep (Hoboken); 2022 Oct; 5(10):e1592. PubMed ID: 34862757
[TBL] [Abstract][Full Text] [Related]
5. RNA-binding proteins as drivers of AML and novel therapeutic targets.
Qin T; Cheng Y; Wang X
Leuk Lymphoma; 2022 May; 63(5):1045-1057. PubMed ID: 35075986
[TBL] [Abstract][Full Text] [Related]
6. m
Liao X; Chen L; Liu J; Hu H; Hou D; You R; Wang X; Huang H
Epigenetics; 2023 Dec; 18(1):2160134. PubMed ID: 36567510
[TBL] [Abstract][Full Text] [Related]
7. A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets.
Adamia S; Haibe-Kains B; Pilarski PM; Bar-Natan M; Pevzner S; Avet-Loiseau H; Lode L; Verselis S; Fox EA; Burke J; Galinsky I; Dagogo-Jack I; Wadleigh M; Steensma DP; Motyckova G; Deangelo DJ; Quackenbush J; Stone R; Griffin JD
Clin Cancer Res; 2014 Mar; 20(5):1135-45. PubMed ID: 24284058
[TBL] [Abstract][Full Text] [Related]
8. RNA-Seq analysis identifies aberrant RNA splicing of TRIP12 in acute myeloid leukemia patients at remission.
Gao P; Jin Z; Cheng Y; Cao X
Tumour Biol; 2014 Oct; 35(10):9585-90. PubMed ID: 24961348
[TBL] [Abstract][Full Text] [Related]
9. Phase separation-competent FBL promotes early pre-rRNA processing and translation in acute myeloid leukaemia.
Yang L; Zhang Z; Jiang P; Kong D; Yu Z; Shi D; Han Y; Chen E; Zheng W; Sun J; Zhao Y; Luo Y; Shi J; Yao H; Huang H; Qian P
Nat Cell Biol; 2024 Jun; 26(6):946-961. PubMed ID: 38745030
[TBL] [Abstract][Full Text] [Related]
10. Effects of Alternative Splicing Events on Acute Myeloid Leukemia.
Chen SL; Dai YJ; Hu F; Wang Y; Li H; Liang Y
DNA Cell Biol; 2020 Nov; 39(11):2040-2051. PubMed ID: 32915082
[TBL] [Abstract][Full Text] [Related]
11. Identification of Nonfunctional Alternatively Spliced Isoforms of STING in Human Acute Myeloid Leukemia.
Boda AR; Liu AJ; Castro-Pando S; Whitfield BT; Molldrem JJ; Al-Atrash G; Di Francesco ME; Jones P; Ager CR; Curran MA
Cancer Res Commun; 2024 Mar; 4(3):911-918. PubMed ID: 38477596
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of splicing factors in newly diagnosed acute myeloid leukemia.
Liu J; Huang B; Xiao Y; Xiong HM; Li J; Feng DQ; Chen XM; Zhang HB; Wang XZ
Onkologie; 2012; 35(6):335-40. PubMed ID: 22722453
[TBL] [Abstract][Full Text] [Related]
13. Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia.
Jin P; Tan Y; Zhang W; Li J; Wang K
Neoplasia; 2020 Sep; 22(9):447-457. PubMed ID: 32653835
[TBL] [Abstract][Full Text] [Related]
14. Long Non-Coding RNA Expression Levels Modulate Cell-Type-Specific Splicing Patterns by Altering Their Interaction Landscape with RNA-Binding Proteins.
Porto FW; Daulatabad SV; Janga SC
Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31390792
[TBL] [Abstract][Full Text] [Related]
15. Identification of survival-related alternative splicing signatures in acute myeloid leukemia.
Zhang B; Yang L; Wang X; Fu D
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212178
[TBL] [Abstract][Full Text] [Related]
16. Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT.
Vadlamudi Y; Dey DK; Kang SC
Curr Cancer Drug Targets; 2020; 20(9):654-665. PubMed ID: 32564755
[TBL] [Abstract][Full Text] [Related]
17. Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine.
Nahas MR; Stroopinsky D; Rosenblatt J; Cole L; Pyzer AR; Anastasiadou E; Sergeeva A; Ephraim A; Washington A; Orr S; McMasters M; Weinstock M; Jain S; Leaf RK; Ghiasuddin H; Rahimian M; Liegel J; Molldrem JJ; Slack F; Kufe D; Avigan D
Br J Haematol; 2019 May; 185(4):679-690. PubMed ID: 30828801
[TBL] [Abstract][Full Text] [Related]
18. Cytarabine-induced TNFα promotes the expansion and suppressive functions of myeloid-derived suppressor cells in acute myeloid leukaemia.
Bai H; Peng Y; Li Y; Duan J; Fu W; Liang X; Yu W; Zhang Q
Scand J Immunol; 2022 Jun; 95(6):e13158. PubMed ID: 35285047
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the clinical significance of global mRNA alternative splicing in patients with acute myeloid leukemia.
Yang YT; Yao CY; Chiu PJ; Kao CJ; Hou HA; Lin CC; Chou WC; Tien HF
Am J Hematol; 2023 May; 98(5):784-793. PubMed ID: 36855936
[TBL] [Abstract][Full Text] [Related]
20. The bone marrow microenvironment - Home of the leukemic blasts.
Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
